The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study
2016 · Clinical Drug Investigation · 50 citations
https://doi.org/10.1007/s40261-016-0462-3
F
Frank R. Ernst
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
107
Papers
3.0K
Citations
20
h-index
31
i10-index
Frank R. Ernst is an academic researcher from Pfizer (United States). The author has contributed to research in topics: Sepsis Diagnosis and Treatment & Hemodynamic Monitoring and Therapy & Pharmaceutical Practices and Patient Outcomes. The author has an h-index of 20, co-authored 91 publications.
ORCID: 0000-0001-6927-9765Papers by this author
worksRelapse outcomes, safety, and treatment patterns in patients diagnosed with relapsing-remitting multiple sclerosis and initiated on subcutaneous interferon<i>β</i>-1a or dimethyl fumarate: a real-world study
2017 · Current Medical Research and Opinion · 13 citations
https://doi.org/10.1080/03007995.2017.1380616
PLASMIC score to aid diagnosis of aHUS: an analysis of C5 inhibitor clinical trials and the PINC AI™ healthcare database
2025 · BMC Nephrology · 1 citations
https://doi.org/10.1186/s12882-025-04156-6
Impact of Risk Stacking on COVID-19–Related Healthcare Utilization: A Real-World Retrospective Cohort Study
2025 · Infectious Diseases and Therapy · 0 citations
https://doi.org/10.1007/s40121-025-01259-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat